1 – 59 of 59
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Cancer-associated fibroblasts rewire the estrogen receptor response in luminal breast cancer, enabling estrogen independence
2024) In Oncogene(
- Contribution to journal › Article
- 2021
-
Mark
Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential
2021) In Oncogene(
- Contribution to journal › Scientific review
- 2020
-
Mark
FRMD6 has tumor suppressor functions in prostate cancer
2020) In Oncogene(
- Contribution to journal › Article
- 2019
-
Mark
The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor
(
- Contribution to journal › Article
-
Mark
Premature activation of Cdk1 leads to mitotic events in S phase and embryonic lethality
(
- Contribution to journal › Article
- 2018
-
Mark
GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine
(
- Contribution to journal › Article
- 2017
-
Mark
GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis
(
- Contribution to journal › Article
- 2016
-
Mark
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Targeting of nucleotide-binding proteins by HAMLET-a conserved tumor cell death mechanism.
2015) In Oncogene(
- Contribution to journal › Article
-
Mark
The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.
(
- Contribution to journal › Article
-
Mark
TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.
(
- Contribution to journal › Article
- 2014
-
Mark
The PI3-kinase isoform p110δ is essential for cell transformation induced by the D816V mutant of c-Kit in a lipid-kinase-independent manner.
(
- Contribution to journal › Article
- 2013
-
Mark
Expression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.
(
- Contribution to journal › Article
-
Mark
MiR-155-mediated loss of C/EBP beta shifts the TGF-beta response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
(
- Contribution to journal › Article
-
Mark
The cocaine- and amphetamine-regulated transcript mediates ligand-independent activation of ER alpha, and is an independent prognostic factor in node-negative breast cancer
(
- Contribution to journal › Article
- 2011
-
Mark
Inactivation of promoter 1B of APC causes partial gene silencing: evidence for a significant role of the promoter in regulation and causative of familial adenomatous polyposis
(
- Contribution to journal › Article
-
Mark
GLI1-dependent transcriptional repression of CYLD in basal cell carcinoma
(
- Contribution to journal › Article
-
Mark
Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysis.
(
- Contribution to journal › Article
- 2010
-
Mark
PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression
(
- Contribution to journal › Article
-
Mark
An integrative genomics screen uncovers ncRNA T-UCR functions in neuroblastoma tumours
(
- Contribution to journal › Article
- 2009
-
Mark
Hematopoietic stem cell ageing is uncoupled from p16(INK4A)-mediated senescence.
(
- Contribution to journal › Article
- 2008
-
Mark
A novel fusion 5 ' AFF3/3 ' BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma
(
- Contribution to journal › Article
- 2007
-
Mark
Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling
(
- Contribution to journal › Article
-
Mark
ERalpha-CITED1 co-regulated genes expressed during pubertal mammary gland development: implications for breast cancer prognosis
(
- Contribution to journal › Article
-
Mark
Arsenic trioxide-induced neuroblastoma cell death is accompanied by proteolytic activation of nuclear Bax.
(
- Contribution to journal › Article
-
Mark
Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
(
- Contribution to journal › Article
-
Mark
IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells
(
- Contribution to journal › Article
- 2006
-
Mark
Endogenous production of leukotriene D(4) mediates autocrine survival and proliferation via CysLT(1) receptor signalling in intestinal epithelial cells.
(
- Contribution to journal › Article
-
Mark
CITED1 homozygous null mice display aberrant pubertal mammary ductal morphogenesis
(
- Contribution to journal › Article
-
Mark
Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.
(
- Contribution to journal › Article
-
Mark
A gene fusion network in human neoplasia.
(
- Contribution to journal › Article
-
Mark
Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays.
(
- Contribution to journal › Article
- 2005
-
Mark
The role of Smad signaling in hematopoiesis.
(
- Contribution to journal › Scientific review
-
Mark
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis
(
- Contribution to journal › Article
-
Mark
Wnt-5a has tumor suppressor activity in thyroid carcinoma
(
- Contribution to journal › Article
-
Mark
ERK1/2 inhibition increases antiestrogen treatment efficacy by interfering with hypoxia-induced downregulation of ERalpha: a combination therapy potentially targeting hypoxic and dormant tumor cells.
(
- Contribution to journal › Article
-
Mark
Microarray analyses reveal strong influence of DNA copy number alterations on the transcriptional patterns in pancreatic cancer: implications for the interpretation of genomic amplifications.
(
- Contribution to journal › Article
-
Mark
A role for cyclin A1 in mediating the autocrine expression of vascular endothelial growth factor in prostate cancer.
(
- Contribution to journal › Article
-
Mark
BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter
(
- Contribution to journal › Article
- 2004
-
Mark
Microarray expression profiling in melanoma reveals a BRAF mutation signature
(
- Contribution to journal › Article
-
Mark
Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells.
(
- Contribution to journal › Article
-
Mark
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.
(
- Contribution to journal › Article
- 2003
-
Mark
ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value
(
- Contribution to journal › Article
- 2002
-
Mark
Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas
(
- Contribution to journal › Article
-
Mark
The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node
(
- Contribution to journal › Article
-
Mark
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers
(
- Contribution to journal › Article
-
Mark
SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF-beta receptor
(
- Contribution to journal › Article
- 2001
-
Mark
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25
(
- Contribution to journal › Article
- 1999
-
Mark
Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction
(
- Contribution to journal › Article
-
Mark
Characterization of the chronic myelomonocytic leukemia associated TEL-PDGF beta R fusion protein
(
- Contribution to journal › Article
-
Mark
SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis
(
- Contribution to journal › Article
-
Mark
Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding
(
- Contribution to journal › Article
- 1998
-
Mark
Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program
(
- Contribution to journal › Article
-
Mark
Identification of Tyr-762 in the platelet-derived growth factor alpha-receptor as the binding site for Crk proteins
(
- Contribution to journal › Article
- 1993
-
Mark
CRK proto-oncogene maps to human chromosome band 17p13
(
- Contribution to journal › Article
- 1991
-
Mark
ERBB2 amplification in breast cancer with a high rate of proliferation
(
- Contribution to journal › Article